AZ announces US fast track designation for IL-5 inhibitor Fasenra
8th November 2021 Uncategorised 0Designation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis
More: AZ announces US fast track designation for IL-5 inhibitor Fasenra
Source: News
